EC therapy activates the PERK–eIF2α–ATF4 signaling pathway to increase ER stress, thereby promoting ferroptosis in lung cancer cells and inhibiting the occurrence and development of lung cancer. The gene discussed is ATF4; the disease is lung cancer.